Джим Коллинз: От хорошего к великому

Winston S. Churchill, The Gathering Storm (Boston: Houghton Mifflin Company, 1948), 667.

Интервью в рамках исследования #2-C, c. 16.

“Man of Steel: Correnti Hopes to Take Nucor to No. 1”, The Business Journal-Charlotte, September 19, 1994, 3.

Standard & Poor’s Industry Survey Database, Metals: Industrial, Iron and Steel, January 18, 2001, Leo J. Larkin, Metals Analyst.

Интервью в рамках исследования #7-C, с. 13.

Интервью в рамках исследования #7-E, с. 7; Jeffrey L. Rodengen, The Legend of Nucor (Write Stuff, 1997), 45.

Jeffrey L. Rodengen, The Legend of Nucor (Write Stuff, 1997), 39.

Интервью в рамках исследования #7-A, с. 3.

Joseph F. Cullman 3rd, I’m a Lucky Guy (Joseph F. Cullman 3rd, 1998), 144; Richard Kluger, Ashes to Ashes (Alfred A. Knopf: New York, 1996), 485; “Beverage management: risky – but straight up 7Up”, Forbes, April 12, 1982, 208; “Coke Peppers 7Up and Pepsi”, Advertising Age, February 24, 1986, 2, 86.

Joseph F. Cullman 3rd, I’m a Lucky Guy (Joseph F. Cullman 3rd, 1998), 147.

John Strohmeyer, Crisis in Bethlehem (Pittsburgh: University of Pittsburgh Press, 1986), 72–73; “The labors of Trautlein”, Forbes, February 15, 1981, 36; “Bethlehem’s Thin Slab Yawn”, American Metal Market, November 17, 1989, 4; “Bethlehem Museum”, National Public Radio Transcript, July 5, 1998.

“Upjohn: Safety of Upjohn’s Oral Antidiabetic Drug Doubted in Study; Firm Disputes Finding”, The Wall Street Journal, May 21, 1970, 6; “Upjohn: A bitter pill for Upjohn shareholders (Drug company involved in antibiotic controversy)”, Financial World, January 23, 1974, 28; “Upjohn: The Upjohn Company: Presentation by R.T. Parfet, Jr., Chairman of the Board and Chief Executive Officer, and L.C. Hoff, Vice President and General Manager, Pharmaceutical Division, to the Security Analysts of San Francisco, September 11, 1975”, The Wall Street Transcript, October 13, 1975, 41648–41650; “Upjohn: Hair-Raising Happenings at Upjohn (Testing a cure for baldness, the company squirms at the unwelcome clamor)”, Fortune, April 6, 1981, 67–69; “Upjohn: FDA Says Upjohn Exaggerated Claims On Drug’s Value in Treating Baldness”, The Wall Street Journal, June 18, 1986, 6; “Upjohn: Rip Tide: Can Upjohn manage its way out of a product gap? If not, it could be swept into the industry merger wave”, Financial World, September 5, 1989, 26–28; “Upjohn: The Corporation: Strategies: Will This Formula Cure What Ails Upjohn: As the sharks circle, it’s spending big on R&D and marketing”, Business Week, September 18, 1989, 65; “Upjohn: Technology & Medicine: Upjohn Sleep Drug Being Investigated For Safety by FDA”, The Wall Street Journal, September 20, 1984, B4; “Upjohn: Medicine: Halcion Takes Another Hit: Tainted data played a key role in FDA approval”, Newsweek, February 17, 1992, 58; “Upjohn: Medicine: Fueling the Fire Over Halcion: Upjohn’s own staff has raised safety concerns”, Newsweek, May 25, 1992, 84; “Upjohn: Top of the News: Successions: At Upjohn, A Grim Changing of the Guard: Ley Smith inherits the problem-plagued drugmaker at a critical juncture”, Business Week, May 3, 1993, 36.

Интервью в рамках исследования #11-B, с. 7.

“No-Longer-So-Great Scott”, Forbes, August 1, 1972, 25.

“Scott Paper Back on its Feet”, Forbes, December 15, 1976, 69–70.

“Scott isn’t lumbering anymore”, Fortune, September 30, 1985, 48–55.

“Scott Paper: Back on the attack”, Financial World, August 1, 1979, 22–23; “A Paper Tiger Grows Claws”, Business Week, August 23, 1969, 100–102; “Outlook For 1970 – Year-End Statement”, Paper Trade Journal, December 22, 1969, 33; “Profits Peak for Scott Paper”, Financial World, April 22, 1970, 13, 28; “No-Longer-So-Great Scott”, Forbes, August 1, 1972, 25.

Интервью в рамках исследования # 5-F, с. 2.

Интервью в рамках исследования # 5-E, с. 22.

Интервью в рамках исследования # 6-A, с. 19.

Ann Kaiser Stearns, Coming Back: Rebuilding Lives after Crisis and Loss (New York: Ballantine, 1988), 294. В своей работе Стернс описывает выводы этих исследований, что, на наш взгляд, научно обосновывает эффективность парадокса Стокдейла. Мы также испытали влияние работы Михая Чиксентмихайи. В комплексном исследовании феномена счастья в книге Flow («Поток») Чиксентмихайи рассматривает возможности трансформации эмоций, вызванных трагедией, используя в качестве примера исследования профессора Миланского университета Фаусто Массимини. В этих исследованиях паралитики и другие больные с нарушениями двигательных функций высказывают мнение, что несчастье послужило для них положительным опытом и заставило в какой-то степени начать жить действительно полной жизнью. (Mihaly Csikszentmihalyi, Flow (HarperPerrenial: 1990), 192–193). Другой взгляд на эту проблему можно найти в работах д-ра Ала Сиеберта, который написал The Survivor Personality – How Life’s Best Survivors Thrive in Difficult Situations and Convert Misfortune into Good Luck.

FNM имел 9,3 % по своим кредитам, но должен был платить 14,63 % по краткосрочным займам. “David Maxwell Takes Over Troubled Fannie Mae”, The Washington Post, May 21, 1981; “Fannie Mae Searches for Higher Ground”, Fortune, July 13, 1981, 110.

“Fannie Mae Searches for Higher Ground”, Fortune, July 13, 1981, 110.

“Fannie Mae Searches for Higher Ground”, Fortune, July 13, 1981, 110.

Разговор с Дэвидом Максвеллом 14 ноября 1997 года.

Tim Brooks and Earle Marsh, The Complete Directory of Primetime Networks and Cable TV Shows (New York: Ballantine, 1999), 929.

Jim and Sybil Stockdale, In Love and War (Maryland: Naval Institute Press, 1990); Stockdale Triumphs, Video Presentation – 1994 Stanford Alumni Association.